Fluidigm Q2 Revenues Rise 58 Percent on Contribution of DVS Acquisition | GenomeWeb

NEW YORK (GenomeWeb) – Fluidigm's second quarter revenues jumped 58 percent year over year, or 32 percent organically, the company reported after the close of the market on Thursday.

For the three months ended June 30, Fluidigm's total revenues increased to $27.6 million from $17.5 million in the year-ago quarter and beat the consensus analysts' estimate of $27.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.